-
-
Almost half of hospitals trying to be compliant with patient safety goals of the Joint Commission on Accreditation of Healthcare Organizations (Joint Commission) still struggle with using unapproved abbreviations, says a field surveyor with the Joint Commission.
-
A certain soft drink has led the way in tests for masking the taste and smell of oral N-acetylcysteine (NAC) in treating acetaminophen poisoning, according to a pharmacist who directs a poison control center. To ensure the best tolerance, however, use the intravenous (IV) formulation rather than the oral one.
-
Strengths/dosage forms available: Paricalcitol is available in 1 mL and 2 mL single-dose vials (5 mcg/mL) of aqueous solution for intravenous (IV) injection, as well as in 1 mcg, 2 mcg, and 4 mcg capsules.
-
Preferred treatment for advanced ovarian cancer announced; CDC updates child/adolescent immunization schedule; CDC: Millions of people carry drug-resistant bacteria; Study: Many patients with NSTE ACS given wrong dose; FDA: Post-marketing rosiglitazone maleate (Avandia) warning
-
The first treatment for advanced renal cell carcinoma has been approved by the FDA in more than a decade.
-
-
As is often said of war, truth may be the first casualty of a bioterrorism attack. In a climate in which misinformation could spur panic, clear, effective communication will be the antidote to chaos.
-
The public must be brought into bioterrorism and mass casualty planning if cooperation and calm are to prevail after the incident, reports the Center for the Advancement of Collaborative Strategies in Health at New York Academy of Medicine.
-
A catastrophic disaster, either natural or man-made, that not only results in widespread casualties but also wipes out medical resources can force health care providers to abandon typical delivery of care and shift to a kind of battlefield medicine, where the sickest patients may not be treated so that care can be delivered to more.
